Related Experiment Video
Updated: Dec 29, 2025

Stable Aqueous Suspensions of Manganese Ferrite Clusters with Tunable Nanoscale Dimension and Composition
Published on: February 5, 2022
Surface-Bound Humic Acid Increased Propranolol Sorption on Fe3O4/Attapulgite Magnetic Nanoparticles
Yuehua Deng1,2, Yani Li1,2
1College of Geology and Environment, Xi'an University of Science and Technology, Xi'an 710054, China.
Abstract:
This study explored the feasibility of utilizing a novel sorbent humic acid (HA) coated Fe3O4/attapulgite (MATP) magnetic nanoparticles (HMATP) for the sorption of propranolol from aqueous solutions. MATP and bare Fe3O4 nanoparticles were also synthesized under similar preparation conditions. The FTIR, Zeta potential, XRD, VSM, TEM, and TGA analyses were conducted to characterize the sorbent materials. The effects of pH, sorbent dosage, ionic strength, HA in the aqueous solution, contact time and initial sorbate concentration on sorption of propranolol were investigated using batch sorption experiments. The results suggested that the sorption capacity of HMATP showed little change from pH 4 to 10. Na+ and Ca2+ slightly inhibited the sorption of propranolol on HMATP. While HA in solution enhanced both MATP and HMATP, which indicated that HMATP can resist HA interference in water. Further, the less leaching amounts of Fe and HA suggested a good stability of HMATP. In all conditions, sorption capacity of propranolol on HMATP was obviously higher than that on MATP, which indicated that surface-coated HA played an important role in the propranolol sorption process. Electrostatic interaction, cation exchange, hydrogen bonding, and π-π electron donor acceptor interactions were considered as the sorption mechanisms.
Related Concept Videos
Bioavailability Enhancement: Drug Permeability Enhancement
Drug Binding to Blood Components
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
Bioavailability Enhancement: Drug Solubility Enhancement
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Bioavailability: Influencing Factors
Drug Distribution: Tissue Binding
For...

